H. Wada

发表

Methylthioadenosine phosphorylase gene is silenced by promoter hypermethylation in human lymphoma cell line DHL-9: another mechanism of enzyme deficiency.

M. Kusunoki, Yasuaki Yamada, S. Kamihira, 2005, International journal of oncology.

Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma‐shock (COT/ACOTS)

J. Thachil, S. Gando, H. Wada, 2013, Journal of thrombosis and haemostasis : JTH.

The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease

H. Wada, K. Yamanaka, K. Habe, 2021, Clinical Rheumatology.

Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura.

M. Murata, Y. Ikeda, H. Wada, 2004, Blood.

Elevated Levels of Prothrombin Fragment 1 + 2 Indicate High Risk of Thrombosis

A. Sudo, A. Uchida, Y. Abe, 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Differential Activation of Eosinophils by Bacteria Associated with Asthma

M. Nagao, T. Fujisawa, T. Nobori, 2013, International Archives of Allergy and Immunology.

Efficiency of diversion of the first aliquot of blood and prestorage leukoreduction for preventing bacterial contamination in red blood cell concentrates assessed using a rapid polymerase chain reaction‐based bacterial detection system

T. Nobori, H. Wada, M. Masuya, 2011, Transfusion medicine.

Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders

Y. Sugimoto, T. Nobori, H. Wada, 2013, European journal of haematology.

Hemostatic Abnormalities in Patients With Thrombotic Complications on Maintenance Hemodialysis

E. Gabazza, H. Shiku, H. Wada, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

H. Shiku, H. Wada, Y. Mori, 1996 .

Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation

H. Wada, S. Shirakawa, K. Deguchi, 1994, American journal of hematology.

Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1992, American journal of hematology.

Decreased Protein C Activation Is Associated With Abnormal Collagen Turnover in the Intraalveolar Space of Patients With Interstitial Lung Disease

J. Risteli, E. Gabazza, Koji Suzuki, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.

H. Wada, M. Matsuda, S. Koga, 2003, Thrombosis and haemostasis.

Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis (ISTH) and of the Japanese Ministry of Health and Welfare for overt DIC

Kaoru Koike, Kohji Okamoto, Hideo Wada, 2003, American journal of hematology.

Analysis of the Cutoff Values in Fibrin-Related Markers for the Diagnosis of Overt DIC

S. Kushimoto, T. Nobori, H. Wada, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Expert consensus for the treatment of disseminated intravascular coagulation in Japan.

S. Madoiwa, I. Maruyama, S. Kushimoto, 2010, Thrombosis research.

Modified non‐overt DIC diagnostic criteria predict the early phase of overt‐DIC

S. Madoiwa, S. Kushimoto, S. Gando, 2010, American journal of hematology.

Pathophysiology and diagnostic criteria for disseminated intravascular coagulation associated with sepsis.

H. Wada, T. Hatada, 2008, Critical care medicine.

PROTEINASE 3 EXPRESSION ON NEUTROPHIL MEMBRANES FROM PATIENTS WITH INFECTIOUS DISEASE

Y. Abe, H. Shiku, T. Nobori, 2006, Shock.

Frequency of Abnormal Biphasic aPTT Clot Waveforms in Patients with Underlying Disorders Associated with Disseminated Intravascular Coagulation

Y. Abe, J. Nishioka, H. Shiku, 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hemostatic study before onset of disseminated intravascular coagulation

Koji Suzuki, H. Wada, S. Tamaki, 1993, American journal of hematology.

Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.

J. Nishioka, H. Wada, T. Hayashi, 1994, Thrombosis and haemostasis.

Outcome of Disseminated Intravascular Coagulation in Relation to the Score when Treatment was Begun

H. Shiku, H. Wada, Y. Mori, 1995, Thrombosis and Haemostasis.

Increased plasma‐soluble fibrin monomer levels in patients with disseminated intravascular coagulation

H. Shiku, H. Wada, H. Deguchi, 1996, American journal of hematology.

Antithrombin and mortality in severe pneumonia patients with sepsis‐associated disseminated intravascular coagulation: an observational nationwide study: comment

H. Wada, K. Suzuki, H. Imai, 2015, Journal of thrombosis and haemostasis : JTH.

Disseminated intravascular coagulation: testing and diagnosis.

H. Wada, T. Hatada, Y. Yamashita, 2014, Clinica chimica acta; international journal of clinical chemistry.

Is early treatment of disseminated intravascular coagulation beneficial in septic patients?

H. Wada, T. Hatada, Y. Yamashita, 2014, Critical Care.

Plasma level of tumor necrosis factor in disseminated intravascular coagulation

H. Wada, M. Takagi, M. Tanigawa, 1991, American journal of hematology.

Conventional therapy with an ACE inhibitor diminishes left ventricular dyssynchrony during the progression of heart failure.

T. Tanigawa, T. Kurita, K. Onishi, 2010, International journal of cardiology.

Effects of atorvastatin on serum lipids, lipoproteins, and hemostasis

Y. Abe, H. Shiku, T. Nobori, 2005, American journal of hematology.

Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells.

Tatsuo Itakura, Y. Abe, J. Nishioka, 2004, International journal of oncology.

New Insights of the Tissue Factor Pathway Inhibitor in Patients with Hypercholesterolemia Treated with Statins.

H. Wada, N. Katayama, Y. Yamashita, 2015, Journal of atherosclerosis and thrombosis.

Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines

J. Thachil, M. Levi, P. Mathew, 2013, Journal of thrombosis and haemostasis : JTH.

Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi‐center prospective study

Y. Ikeda, T. Nagasawa, S. Nomura, 2006, Journal of thrombosis and haemostasis : JTH.

Exaggerated Hypertensive Response to Exercise in Patients with Diastolic Heart Failure

T. Yamanaka, K. Onishi, Masaaki Ito, 2008, Hypertension Research.

Plasma levels of activated protein C–protein C inhibitor complex in patients with hypercoagulable states

J. Nishioka, E. Gabazza, Koji Suzuki, 2000, American journal of hematology.

Central venous catheter‐related thrombosis after replacement therapy for intracranial bleeding in a patient with afibrinogenaemia

Y. Sugimoto, T. Nobori, H. Wada, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer

C. Miki, E. Gabazza, H. Shiku, 2002, American journal of hematology.

Haemostatic abnormalities and thrombotic disorders in malignant lymphoma

Y. Abe, J. Nishioka, H. Shiku, 2004, Thrombosis and Haemostasis.

Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.

S. Uemoto, T. Nobori, H. Wada, 2013, Thrombosis research.

Decreased ADAMTS13 levels in patients after living donor liver transplantation.

T. Nobori, H. Wada, M. Matsumoto, 2009, Thrombosis research.

Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines

H. Wada, Y. Yamashita, Takeshi Matsumoto, 2014, Journal of Intensive Care.

Hemostatic abnormality of lymphoid tumors.

H. Wada, S. Shirakawa, H. Suzuki, 1988 .

Relationship between CYP2C19 loss-of-function polymorphism and platelet reactivities with clopidogrel treatment in Japanese patients undergoing coronary stent implantation.

T. Tanigawa, K. Nakatani, Masaaki Ito, 2013, Circulation journal : official journal of the Japanese Circulation Society.

Highly increased plasma concentrations of the nicked form of beta(2) glycoprotein I in patients with leukemia and with lupus anticoagulant: measurement with a monoclonal antibody specific for a nicked form of domain V.

N. Ohkura, H. Shiku, H. Kato, 2000, Journal of biochemistry.

Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects.

J. Nishioka, K. Nakatani, T. Nobori, 2005, International journal of molecular medicine.

Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan

Y. Miyakawa, T. Miyata, K. Kokame, 2017, International Journal of Hematology.

Evaluation of tissue factor antigen level in human seminal plasma

H. Fuse, E. Gabazza, T. Nobori, 2002, Urological Research.

Nitric oxide stimulates glucose transport through insulin-independent GLUT4 translocation in 3T3-L1 adipocytes.

E. Gabazza, K. Nakatani, T. Nobori, 2003, European journal of endocrinology.

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

H. Shiku, H. Wada, Y. Mori, 1996, American journal of hematology.

Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease

E. Gabazza, Koji Suzuki, H. Shiku, 1999, American journal of hematology.

Plasma‐activated factor VII level in patients positive for lupus anticoagulant

H. Shiku, H. Wada, H. Deguchi, 1997, American journal of hematology.

Effect of lipoproteins on tissue factor activity and PAI-II antigen in human monocytes and macrophages.

H. Wada, S. Tamaki, S. Shirakawa, 1994, International journal of cardiology.

Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia

Koji Suzuki, H. Wada, M. Tanigawa, 1993, American journal of hematology.

Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura.

H. Shiku, T. Nobori, H. Wada, 2007, Thrombosis research.

Reduced Cd 4 + Cd 25 + T cells in patients with idiopathic thrombocytopenic purpura

H. Shiku, T. Nobori, H. Wada, 2006 .

Molecular diagnosis of nonaneurysmal infectious aortitis.

H. Wada, H. Shimpo, Kiyohito Yamamoto, 2011, Journal of vascular surgery.

Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation

H. Shiku, H. Wada, K. Nishii, 1999, American journal of hematology.

High Plasma Level of Factor VIII

Masaaki Ito, H. Wada, A. Tsuji, 2011 .

Frequent association of thrombophilia in cerebral venous sinus thrombosis

Y. Abe, M. Ikejiri, K. Nakatani, 2012, International Journal of Hematology.

[Risk factors].

H. Wada, Y. Kamikura, 2018, Nihon rinsho. Japanese journal of clinical medicine.

Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux

A. Sudo, A. Uchida, M. Hasegawa, 2012, International Journal of Hematology.

Platelet Function in Watanabe Heritable Hyperlipidemic Rabbits, a Model for the Progression of Atherosclerosis

T. Kita, H. Wada, M. Takagi, 1991 .

Coagulability in Watanabe heritable hyperlipidemic (WHHL) rabbit

T. Kita, K. Ishii, H. Wada, 1987 .

Supportive management strategies for disseminated intravascular coagulation

M. Di Nisio, J. Thachil, V. Vicente, 2015, Thrombosis and Haemostasis.

Donor Age Affects Liver Regeneration during Early Period in the Graft Liver and Late Period in the Remnant Liver after Living Donor Liver Transplantation

Tomomi Yamada, Hideo Wada, Tomomi Yamada, 2012, World Journal of Surgery.

Platelets Activation and Liver Transplantation

H. Wada, S. Isaji, S. Mizuno, 2017 .

Elevated Soluble Platelet Glycoprotein VI Levels in Patients After Living Donor Liver Transplantation

S. Uemoto, H. Wada, Toshihiko Kobayashi, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Differential Activation of Eosinophils by ‘Probiotic’ Bifidobacterium bifidum and ‘Pathogenic’ Clostridium difficile

M. Nagao, T. Fujisawa, T. Nobori, 2010, International Archives of Allergy and Immunology.

Protein C anticoagulant system in patients with interstitial lung disease.

J. Nishioka, E. Gabazza, H. Wada, 1998, American journal of respiratory and critical care medicine.

Plasma ADAMTS13, von Willebrand Factor (VWF), and VWF Propeptide Profiles in Patients With Connective Tissue Diseases and Antiphospholipid Syndrome

T. Ikeda, M. Ikejiri, H. Wada, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases

Y. Abe, J. Nishioka, H. Shiku, 2004, Thrombosis and Haemostasis.

Attempt to Harvest a Sufficient Number of Mononuclear Cells in an Appropriate Blood Product Volume By Modification of the Default Apheresis Setting

T. Tanigawa, H. Shiku, Masaaki Ito, 2017, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Staphylococcus aureus directly activates eosinophils via platelet‐activating factor receptor

M. Nagao, T. Fujisawa, T. Nobori, 2012, Journal of leukocyte biology.

Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with direct oral anticoagulant

A. Sudo, M. Hasegawa, H. Wakabayashi, 2017, Thrombosis Journal.

State-of-the-Art Review : Coagulation Tests and Anti-Phospholipid Antibodies in Patients Positive for Lupus Anticoagulant

H. Shiku, Y. Okugawa, H. Wada, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

H. Wada, M. Matsumoto, Y. Fujimura, 2004, Seminars in hematology.

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF‐cleaving protease activity

E. Gabazza, H. Shiku, T. Nobori, 2002, Transfusion.

Hemostatic Abnormalities and Liver Diseases

H. Wada, N. Sakuragawa, M. Usui, 2008, Seminars in thrombosis and hemostasis.

The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis

S. Madoiwa, H. Wada, K. Kawasugi, 2017, Thrombosis Journal.

Plasma levels of activated FVII in various diseases.

H. Shiku, H. Wada, Y. Mori, 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

H. Wada, N. Sakuragawa, 2008, Seminars in thrombosis and hemostasis.

Comparison of disseminated intravascular coagulation in trauma with coagulopathy of trauma/acute coagulopathy of trauma‐shock

J. Thachil, S. Gando, H. Wada, 2012, Journal of thrombosis and haemostasis : JTH.

Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1993, American journal of hematology.

Hypofibrinogenemia is Associated With a High Degree of Risk in Infectious and Hematological Diseases: A Post-Hoc Analysis of Post-Marketing Surveillance of Patients With Disseminated Intravascular Coagulation Treated With Thrombomodulin Alfa

S. Madoiwa, T. Ikezoe, T. Iba, 2020 .

The prothrombin time ratio is not a more effective marker for evaluating sepsis‐induced coagulopathy than fibrin‐related markers

M. Shimaoka, K. Shiraki, H. Wada, 2020, Journal of thrombosis and haemostasis : JTH.

Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura.

T. Ikeda, M. Ikejiri, H. Wada, 2016, Internal medicine.

Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases

T. Ikeda, M. Ikejiri, T. Nobori, 2013, International Journal of Hematology.

Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.

K. Asanuma, Kanako Saito, H. Wada, 2014, Internal medicine.

Elevated Fibrin-Related Markers in Patients with Malignant Diseases Suspected of Having Thrombotic Disorders

A. Sudo, Kanako Saito, T. Nobori, 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery

A. Sudo, A. Uchida, Koji Suzuki, 2009, International journal of hematology.

Elevated levels of soluble fibrin in patients with venous thromboembolism

A. Sudo, A. Uchida, Y. Abe, 2008, International journal of hematology.

Negative predictive value of d-dimer for diagnosis of venous thromboembolism

A. Sudo, A. Uchida, Y. Abe, 2008, International journal of hematology.

Elevated levels of soluble fibrin or D‐dimer indicate high risk of thrombosis

A. Sudo, A. Uchida, Y. Abe, 2006, Journal of thrombosis and haemostasis : JTH.

Diagnosis of deep vein thrombosis by plasma‐soluble fibrin or D‐dimer

Y. Abe, T. Nakano, J. Nishioka, 2005, American journal of hematology.

Neutrophil elastase affects not only tissue damage, but it also regulates hematopoiesis.

H. Wada, K. Habe, 2011, Thrombosis research.

The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE

A. Sudo, M. Hasegawa, H. Wakabayashi, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery

A. Sudo, M. Hasegawa, H. Wakabayashi, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response

R. Allen, E. Hack, F. Taylor, 2001, Critical care medicine.

Neurotrophic receptor tyrosine kinase B induces c-fos-associated cell survival.

J. Nishioka, K. Nakatani, T. Nobori, 2009, International journal of molecular medicine.

Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1993, American journal of hematology.

Hypercoagulable State in the Watanabe Heritable Hyperlipidemic Rabbit, an Animal Model for the Progression of Atherosclerosis

T. Kita, H. Wada, S. Shirakawa, 1989, Thrombosis and Haemostasis.

Regulation of myosin phosphatase through phosphorylation of the myosin-binding subunit in platelet activation.

K. Kaibuchi, H. Shiku, H. Wada, 1997, Blood.

Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases.

T. Nobori, H. Wada, H. Mizutani, 2012, Thrombosis research.

Decreased Plasma Tissue Factor Pathway Inhibitor Levels in Patients with Thrombotic Thrombocytopenic Purpura

H. Shiku, H. Wada, M. Shimura, 1995, Thrombosis and Haemostasis.

Increased Plasma Soluble-adhesion Molecules in Thrombotic Thrombocytopenic Purpura and Disseminated Intravascular Coagulation

H. Shiku, H. Wada, M. Takagi, 1998 .

Usefulness of Measurement of Reticulated Platelets for Diagnosis of Idiopathic Thrombocytopenic Purpura

Y. Abe, J. Nishioka, H. Shiku, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Usefulness of Fully Automated Measurement of Reticulated Platelets Using Whole Blood

Y. Abe, J. Nishioka, H. Shiku, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Molecular diagnosis of prosthetic valve endocarditis with aorto-right atrial fistula.

K. Onishi, Masaaki Ito, T. Nobori, 2009, International journal of cardiology.

Mycotic Aortic Aneurysm Associated with Legionella anisa

Masaaki Ito, T. Nobori, H. Wada, 2009, Journal of Clinical Microbiology.

Update on the Clot Waveform Analysis

M. Shimaoka, K. Shiraki, H. Wada, 2020, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Cilostazol down-regulates the height of mural platelet thrombi formed under a high-shear rate flow in the absence of ADAMTS13 activity.

H. Wada, M. Matsumoto, Y. Fujimura, 2012, European journal of pharmacology.

Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction

M. Shimaoka, K. Shiraki, H. Wada, 2021, Journal of clinical medicine.

Hypofibrinogenemia and the α-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss

T. Ikeda, M. Ikejiri, K. Nakatani, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hemostatic Abnormalities and Changes Following Bone Marrow Transplantation

H. Shiku, T. Nobori, H. Wada, 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Hemostatic molecular markers before the onset of disseminated intravascular coagulation

E. Gabazza, H. Shiku, H. Wada, 1999, American journal of hematology.

[Dysfibrinogenemia developed in a pregnant woman who has fibrinogen AαThr312Ala (ACT/GCT) polymorphism].

H. Wada, M. Wada, Ayaka Yamaguchi, 2016, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome.

H. Yamada, M. Nangaku, S. Honda, 2013, Molecular immunology.

Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux

A. Sudo, K. Asanuma, M. Hasegawa, 2016, International Journal of Hematology.

The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.

A. Sudo, A. Uchida, K. Asanuma, 2013, Clinica chimica acta; international journal of clinical chemistry.

Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement

A. Sudo, A. Uchida, M. Hasegawa, 2011, International journal of hematology.

Successful treatment of deep vein thrombosis in homozygous protein C deficiency with activated protein C

H. Wada, K. Suzuki, S. Shirakawa, 1993, American journal of hematology.

Late-onset homozygous protein C deficiency manifesting cerebral infarction as the first symptom at age 27.

H. Wada, S. Shirakawa, T. Tsukada, 1992, Internal medicine.

Congenital Thrombophilia in Patients With Superior Mesenteric Venous Thrombosis or Portal Vein Thrombosis

K. Nakatani, H. Wada, H. Tomimoto, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Changes of Hemostatic Molecular Markers After Gynecological Surgery

E. Gabazza, K. Noda, H. Shiku, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The Plasma Levels of ADAMTS-13, von Willebrand Factor, VWFpp, and Fibrin-Related Markers in Patients With Systemic Sclerosis Having Thrombosis

H. Wada, H. Mizutani, K. Ohishi, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion.

Y. Kataoka, H. Shiku, H. Wada, 2001, Blood.

The Membrane Proteinase 3 Expression on Neutrophils Was Downregulated After Treatment With Infliximab in Patients With Rheumatoid Arthritis

A. Sudo, A. Uchida, H. Shiku, 2008, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

High frequency of decreased antithrombin level in pregnant women with thrombosis

T. Ikeda, M. Ikejiri, K. Nakatani, 2015, International Journal of Hematology.

Anti-Xa activity in VTE patients treated with fondaparinux.

Masaaki Ito, H. Wada, N. Yamada, 2015, Clinica chimica acta; international journal of clinical chemistry.

Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk

T. Iba, M. Ikejiri, H. Wada, 2019, Thrombosis Journal.

Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients

M. Shimaoka, K. Shiraki, H. Wada, 2020, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

A. Sudo, K. Asanuma, M. Hasegawa, 2016, International Journal of Hematology.

Role of hematological tests for medical care

H. Wada, Takeshi Matsumoto, 2013 .

Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism.

Y. Abe, T. Nakano, J. Nishioka, 2005, Thrombosis research.

Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis.

T. Nakano, H. Shiku, T. Nobori, 2005, Thrombosis research.

Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes.

E. Gabazza, Koji Suzuki, H. Wada, 1997, Blood.

Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo.

Yasuo Ikeda, E. Imai, Y. Ikeda, 1997, Life sciences.

Usefulness of a Diluted Prothrombin Time for Accurately Diagnosing Antiphospholipid Syndrome

Y. Abe, M. Ikejiri, K. Nakatani, 2009 .

High prevalence of anti‐prothrombin antibody in patients with deep vein thrombosis

T. Nakano, T. Nobori, H. Wada, 2004, American journal of hematology.

State-of-the-Art Review : Elevated Tissue Factor Levels in Leukemic Cell Homogenate

E. Gabazza, H. Shiku, H. Wada, 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Plasma Tissue Factor Antigen Level in Patients with Disseminated Intravascular Coagulation

H. Wada, S. Tamaki, S. Shirakawa, 1994 .

Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy

T. Iba, H. Wada, M. Matsumoto, 2018, Thrombosis Journal.

A second national questionnaire survey of TMA

M. Murata, Y. Ikeda, H. Wada, 2010, International journal of hematology.

National questionnaire survey of TMA

M. Murata, Y. Ikeda, H. Wada, 2009, International journal of hematology.

State-of-the-Art Review : Outcome of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in Japan

H. Shiku, H. Wada, S. Tamaki, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries

H. Shiku, H. Wada, M. Ioka, 1998, American journal of hematology.

A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH

J. Thachil, T. Iba, H. Wada, 2018, Journal of thrombosis and haemostasis : JTH.

Tissue factor expression in endothelial cells in health and disease

H. Shiku, H. Wada, Y. Wakita, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

High plasma fibrinogen level is associated with poor clinical outcome in DIC patients

E. Gabazza, H. Shiku, T. Nobori, 2003, American journal of hematology.

Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: Toward a better definition of DIC

F. Taylor, G. Kinasewitz, H. Wada, 2000, Critical care medicine.

Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

M. Murata, H. Wada, M. Matsumoto, 2011, Thrombosis research.

A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC

M. Di Nisio, J. Thachil, D. Saitoh, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The evaluation of a scoring system for diagnosing atypical hemolytic uremic syndrome

M. Shimaoka, K. Shiraki, H. Wada, 2020 .

Clinical Manifestation of Patients With Atypical Hemolytic Uremic Syndrome With the C3 p.I1157T Variation in the Kinki Region of Japan

T. Miyata, H. Toyoda, M. Ikejiri, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation

T. Miyata, H. Toyoda, M. Ikejiri, 2014, International Journal of Hematology.

Calyculin A retraction of mature megakaryocytes proplatelets from embryonic stem cells.

K. Eto, H. Wada, N. Katayama, 2008, Biochemical and biophysical research communications.

A novel Wiskott–Aldrich syndrome protein mutation in an infant with thrombotic thrombocytopenic purpura

O. Ohara, T. Morio, K. Imai, 2013, European journal of haematology.

Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis

H. Wada, K. Suzuki, M. Takagi, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Response of the cubital vein to occlusion and calcification of the abdominal aorta in patients with chronic renal failure on maintenance hemodialysis.

H. Wada, S. Shirakawa, K. Deguchi, 1988, Thrombosis research.

Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.

H. Wada, S. Shirakawa, K. Deguchi, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

H. Shiku, H. Wada, M. Shimura, 1996, American journal of hematology.

[Plasma thrombomodulin levels in elderly subjects].

H. Wada, H. Ishii, S. Shirakawa, 1991, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

Group A streptococcal toxic shock syndrome with extremely aggressive course in the third trimester

H. Wada, N. Sagawa, T. Hatada, 2010, The journal of obstetrics and gynaecology research.

High plasma level of factor VIII: an important risk factor for venous thromboembolism.

Masaaki Ito, H. Wada, A. Tsuji, 2011, Circulation journal : official journal of the Japanese Circulation Society.

EFFICACY OF PROCALCITONIN IN THE EARLY DIAGNOSIS OF BACTERIAL INFECTIONS IN A CRITICAL CARE UNIT

J. Nishioka, M. Ikejiri, T. Nobori, 2008, Shock.

Effect of Pravastatin® on Coagulation and Fibrinolytic Systems in Patients with Hypercholesterolemia

A. Noda, H. Wada, M. Tanigawa, 1991 .

A novel protein S gene mutation combined with protein S Tokushima mutation in a patient with superior sagittal sinus thrombosis

M. Ikejiri, K. Nakatani, T. Nobori, 2011, Journal of Neurology.

Cerebral venous thrombosis

H. Wada, H. Tomimoto, A. Shindo, 2014 .

Hemostatic abnormalities and leukocyte activation caused by infection in patients with malignant lymphoma during chemotherapy.

Y. Abe, J. Nishioka, H. Shiku, 2006, Thrombosis research.

Hypercoagulant states in malignant lymphoma.

H. Wada, M. Yamaguchi, T. Sase, 2005, Experimental oncology.

Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab

H. Wada, N. Katayama, H. Imai, 2019, International Journal of Hematology.

Hemostatic Abnormalities Following Bone Marrow Transplantation

E. Gabazza, T. Nobori, H. Wada, 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction

Tatsuya Hayashi, Koji Suzuki, H. Shiku, 1995, American journal of hematology.

Granulocyte colony‐stimulating factor and its receptor in acute promyelocytic leukemia

H. Shiku, H. Wada, K. Nishii, 1998, American journal of hematology.

Erratum to: Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of history of splenectomy: the significance of ADAMTS13 and graft function

S. Uemoto, T. Nobori, H. Wada, 2014, International Journal of Hematology.

Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of history of splenectomy: the significance of ADAMTS13 and graft function

S. Uemoto, T. Nobori, H. Wada, 2014, International Journal of Hematology.

The Effectiveness of Measuring for Fragmented Red Cells Using an Automated Hematology Analyzer in Patients With Thrombotic Microangiopathy

Y. Abe, J. Nishioka, M. Ikejiri, 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Pregnancy‐induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw–Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients

J. George, T. Miyata, K. Kokame, 2009, British journal of haematology.

Shinsuke Nomura, K. Nakatani, T. Nobori, 2008, Thrombosis research.

Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura.

H. Shiku, T. Nobori, H. Wada, 2007, Thrombosis research.

Expression of endothelial nitric oxide synthase is induced by estrogen with glycogen synthase 3beta phosphorylation in MCF-7 cells.

K. Nakatani, T. Nobori, H. Wada, 2004, Oncology reports.

Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy.

M. Ikejiri, H. Wada, N. Katayama, 2019, Thrombosis research.

Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome

M. Nangaku, T. Miyata, K. Kokame, 2018, Clinical and Experimental Nephrology.

Plasminogen activators and their inhibitors in leukemic cell homogenates

Y. Kumeda, H. Wada, S. Tamaki, 1993, American journal of hematology.

Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.

E. Gabazza, H. Shiku, T. Nobori, 2001, Thrombosis research.

Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH

J. Thachil, M. Levi, T. Iba, 2019, Journal of thrombosis and haemostasis : JTH.

The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases.

J. Thachil, M. Levi, T. Iba, 2019, Thrombosis research.

Platelet Activation Assessed by Glycoprotein VI/Platelet Ratio Is Associated With Portal Vein Thrombosis After Hepatectomy and Splenectomy in Patients With Liver Cirrhosis

N. Kuriyama, H. Wada, M. Kishiwada, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Elevated plasma levels of soluble platelet glycoprotein VI (GPVI) in patients with thrombotic microangiopathy.

M. Ikejiri, H. Wada, N. Katayama, 2014, Thrombosis research.

Elevated Von Willebrand factor propeptide for the diagnosis of thrombotic microangiopathy and for predicting a poor outcome

Shinsuke Nomura, H. Toyoda, Masaaki Ito, 2011, International journal of hematology.

Infective Endocarditis Caused by Panton-Valentine Leukocidin-producing Methicillin-susceptible Staphylococcus aureus Identified by the Broad-range PCR Method.

Masaaki Ito, T. Nobori, H. Wada, 2016, Internal medicine.

Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation

F B Taylor, F. Taylor, M. Levi, 2001, Thrombosis and Haemostasis.

[Tissue factor pathway in disseminated intravascular coagulation].

H. Wada, M. Simura, 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology.

A case of three‐year‐old boy with severe haemophilia A on prophylaxis identified with a chronic subdural haematoma 2 years after the first episode of acute subdural bleeding

H. Wada, Y. Komada, K. Ohishi, 2012, Haemophilia.

Life-Threatening Tongue and Retropharyngeal Hemorrhage in a Patient with Hemophilia A with Inhibitors

H. Wada, N. Katayama, I. Tawara, 2019, The American journal of case reports.

[Disseminated intravascular coagulation].

H. Wada, 2004, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Cyclic AMP in Leukemic Cell Lysate in Disseminated Intravascular Coagulation

H. Hidaka, T. Tanaka, Tohru Kobayashi, 1992 .

A novel frameshift mutation in exon 4 causing a deficiency of high-molecular-weight kininogen in a patient with splenic infarction.

H. Masaki, S. Kimura, Y. Komiyama, 2014, Internal medicine.

Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation

E. Gabazza, H. Shiku, H. Kato, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation

E. Gabazza, H. Shiku, H. Wada, 1999, American journal of hematology.

Aberrations of the Tissue Factor Pathway in Patients Positive for Lupus Anticoagulant

E. Gabazza, H. Shiku, H. Wada, 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Spa bathing activates fibrinolysis in patients with cerebral infarction.

H. Wada, S. Shirakawa, M. Nishikawa, 1993, Internal medicine.

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis

Kohji Okamoto, Hideo Wada, S. Madoiwa, 2016, Thrombosis Journal.

Successful treatment of non‐invasive bladder tumour in a haemophilia A patient with high‐responding inhibitors: a case report

H. Wada, Takeshi Sasaki, Y. Sugimura, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Monitoring of hemostatic abnormalities in major orthopedic surgery patients treated with edoxaban by APTT waveform

A. Sudo, M. Hasegawa, H. Wakabayashi, 2018, International journal of laboratory hematology.

Coagulation factor V inhibitors, a review of the case report literature

M. Shimaoka, K. Shiraki, H. Wada, 2021, Thrombosis Update.

Effects of platelet and phospholipids on clot formation activated by a small amount of tissue factor.

M. Shimaoka, K. Shiraki, H. Wada, 2020, Thrombosis research.

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab: comment

H. Toyoda, H. Wada, M. Hirayama, 2018, Journal of thrombosis and haemostasis : JTH.

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform

Y. Abe, M. Ikejiri, H. Wada, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

H. Wada, N. Katayama, Takeshi Matsumoto, 2017, The New England journal of medicine.

The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay

M. Shimaoka, K. Shiraki, H. Wada, 2021, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.

H. Wada, N. Katayama, Takeshi Matsumoto, 2017, The New England journal of medicine.

The Evaluation of Hemostatic Abnormalities Using a CWA-Small Amount Tissue Factor Induced FIX Activation Assay in Major Orthopedic Surgery Patients

M. Shimaoka, A. Sudo, M. Hasegawa, 2021, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Decreased tissue factor and tissue‐plasminogen activator antigen in relapsed acute promyelocytic leukemia

E. Gabazza, H. Shiku, H. Kato, 2000, American journal of hematology.

Treatment of DIC

H. Wada, H. Nomura, 2008 .

Hemostatic markers and the sepsis‐related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit

T. Nobori, H. Wada, K. Maruyama, 2004, American journal of hematology.

Personalized treatment in the eradication therapy for Helicobacter pylori.

J. Nishioka, K. Nakatani, T. Nobori, 2011, International journal of molecular medicine.

Modification of factor VIII by thrombin and factor Xa

H. Wada, S. Shirakawa, K. Deguchi, 1984 .

Effect of Polymyxin B on platelet aggregation induced by arachidonate

H. Wada, S. Shirakawa, M. Nishikawa, 1988 .

Effects of Lipid Abnormalities on Arteriosclerosis and Hemostatic Markers in Patients under Hemodialysis

E. Gabazza, T. Nobori, H. Wada, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

PCR-Mediated Early Diagnosis of Fungal infections in Patients with Living-Donor Liver Transplants

J. Nishioka, T. Nobori, H. Wada, 2009 .

S-100 antigen and calmodulin in human leukemic cells.

H. Hidaka, H. Wada, S. Shirakawa, 1989, Leukemia research.

on be half of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH)

F. Taylor, M. Levi, W. Hoots, 2001 .

A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF).

Y. Abe, J. Nishioka, K. Nakatani, 2006, Thrombosis research.

Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.

Y Suzuki, S. Narumiya, H. Shiku, 1999, Blood.

The efficacy of the administration of recombinant human soluble thrombomodulin in patients with DIC

H. Wada, K. Ohishi, N. Katayama, 2016, International Journal of Hematology.

A prospective analysis of disseminated intravascular coagulation in patients with infections.

S. Kushimoto, H. Wada, K. Kawasugi, 2013, Internal medicine.

Diagnostic criteria and laboratory tests for disseminated intravascular coagulation.

H. Wada, T. Kaneko, 2011, Journal of clinical and experimental hematopathology : JCEH.

Disseminated mycobacterial infection in a hemophilia B patient with acquired immunodeficiency syndrome.

H. Wada, M. Tanigawa, S. Tamaki, 1990, Japanese journal of medicine.

[Progress in diagnosis and treatment for disseminated intravascular coagulation].

H. Wada, Y. Yamashita, Takeshi Matsumoto, 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients

M. Ikejiri, H. Wada, H. Tomimoto, 2014, International Journal of Hematology.

Plasma Levels of Total Plasminogen Activator Inhibitor-I (PAI-I) and tPA/PAI-1 Complex in Patients With Disseminated Intravascular Coagulation and Thrombotic Thrombocytopenic Purpura

E. Gabazza, H. Shiku, Y. Okugawa, 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Analysis three abnormal Protein S genes in a patient with pulmonary embolism.

J. Nishioka, M. Ikejiri, K. Nakatani, 2010, Thrombosis research.

Calcium binding to abnormal fibrinogens with a single amino acid replacement in the NH2-terminal region of fibrin α - or β-chain

H. Hirata, H. Wada, S. Asakura, 1992 .

A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.

H. Hirata, H. Wada, S. Asakura, 1991, Blood.

replacement of B beta glycine-15 by cysteine A new congenital abnormal fibrinogen Ise characterized by the

H. Hirata, H. Wada, S. Asakura, 2013 .

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa

S. Madoiwa, T. Ikezoe, T. Iba, 2021, Thrombosis Journal.

Severe Antithrombin Deficiency May be Associated With a High Risk of Pathological Progression of DIC With Suppressed Fibrinolysis

S. Madoiwa, T. Ikezoe, T. Iba, 2020, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation

Y. Abe, S. Yamada, I. Maruyama, 2005, Thrombosis and Haemostasis.

Atherosclerotic and Hemostatic Abnormalities in Patients Undergoing Hemodialysis

E. Gabazza, T. Nobori, H. Wada, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Plasma Levels of Plasminogen Activator Inhibitor-1 (PAI-1) and Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Disseminated Intravascular Coagulation (DIC).

H. Shiku, T. Nobori, H. Wada, 2002, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Stimulation of tissue type plasminogen activator by leukaemic cell homogenates

Y. Kumeda, H. Wada, S. Shirakawa, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey.

T. Iba, H. Wada, Daizoh Saito, 2012, Thrombosis research.

Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections

T. Iba, S. Gando, H. Wada, 2006, Thrombosis and Haemostasis.

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity

M. Di Nisio, J. Thachil, D. Saitoh, 2016, Critical Care.

The association of protein S Tokushima-K196E with a risk of deep vein thrombosis

J. Nishioka, M. Ikejiri, K. Nakatani, 2010, International journal of hematology.

Plasma Levels of Heparin Cofactor II (HCII) and Thrombin-HCII Complex in Patients with Disseminated Intravascular Coagulation

E. Gabazza, H. Shiku, K. Nakatani, 2002, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prevention of venous thromboembolism (VTE) in ICU: an overview of newly developed anticoagulants

T. Iba, H. Wada, 2012 .

Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis

T. Nakano, H. Shiku, H. Wada, 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Diagnostic criteria and laboratory tests for disseminated intravascular coagulation

H. Wada, Takeshi Matsumoto, Tuyoshi Hatada, 2012, Expert review of hematology.

Anticoagulant Activity in Cell Homogenate of Adult T Cell Leukemia

H. Wada, S. Shirakawa, A. Deguchi, 1988, Thrombosis and Haemostasis.

Molecular characterization of coagulation factor XII deficiency in a Japanese family

Y. Abe, J. Nishioka, K. Nakatani, 2003, Thrombosis and Haemostasis.

Factor VII Mie: Homozygous Asymptomatic Type I Deficiency Caused by an Amino Acid Substitution of His (CAC) for Arg(247) (CGC) in the Catalytic Domain

Tatsuya Hayashi, Koji Suzuki, H. Wada, 1994, Thrombosis and Haemostasis.

Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring.

J. Nishioka, E. Gabazza, H. Shiku, 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura.

M. Kondo, H. Toyoda, H. Wada, 2013, The Journal of allergy and clinical immunology.

Sepsis-associated disseminated intravascular coagulation and its differential diagnoses

S. Kushimoto, Y. Umemura, T. Iba, 2019, Journal of Intensive Care.

Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation

H. Shiku, T. Kato, H. Wada, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy.

H. Shiku, T. Kato, H. Wada, 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Hypercoagulable state in patients with hypercholesterolemia: effects of pravastatin.

H. Wada, S. Tamaki, K. Deguchi, 1992, Clinical therapeutics.

Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations

H. Wada, H. Mizutani, K. Yamanaka, 2019, Scientific Reports.

Plasma Level of IL-1β in Disseminated Intravascular Goagulation

H. Wada, N. Katayama, M. Takagi, 1991, Thrombosis and Haemostasis.

Diagnostic Value of PCR Analysis of Bacteria and Fungi from Blood in Empiric-Therapy-Resistant Febrile Neutropenia

Y. Sugimoto, T. Nobori, H. Wada, 2010, Journal of Clinical Microbiology.

Coagulant and fibrinolytic activities in the leukemic cell lysates.

H. Wada, S. Shirakawa, Y. Karitani, 1983, Thrombosis research.

Evaluation of New Japanese Diagnostic Criteria for Disseminated Intravascular Coagulation in Critically Ill Patients

M. Nakagawa, A. Murata, T. Iba, 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases

Y. Abe, J. Nishioka, E. Gabazza, 2003, Thrombosis and Haemostasis.

Diagnostic Criteria for Disseminated Intravascular Coagulation (DIC) in International Society of Thrombosis and Hemostasis and Japan

H. Wada, 2000 .

Hemostatic abnormalities and increased vascular endothelial cell markers in patients with red cell fragmentation syndrome induced by mitomycin C

H. Shiku, H. Wada, M. Tanigawa, 1995, American journal of hematology.

Plasma cytokine levels in thrombotic thrombocytopenic purpura

H. Wada, M. Tanigawa, S. Tamaki, 1992, American journal of hematology.

Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban

A. Sudo, A. Uchida, K. Asanuma, 2014, International Journal of Hematology.

Increased plasma levels of tissue factor pathway inhibitor‐activated factor X complex in patients with disseminated intravascular coagulation

E. Gabazza, H. Shiku, Y. Okugawa, 2000, American journal of hematology.

Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation

M. Shimaoka, K. Shiraki, T. Iba, 2021, Journal of clinical medicine.

Increased Ratio of Soluble Fibrin Formation/Thrombin Generation in Patients With DIC

S. Kushimoto, T. Nobori, H. Wada, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

An Evaluation of the Activated Partial Thromboplastin Time Waveform

Y. Abe, M. Ikejiri, K. Nakatani, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.

T. Nakano, T. Tanigawa, Y. Ikeda, 2001, American heart journal.

Cardiovascular events occur independently of high on-aspirin platelet reactivity and residual COX-1 activity in stable cardiovascular patients

K. Kario, N. Yonemoto, K. Kitagawa, 2016, Thrombosis and Haemostasis.

Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.

T. Nakano, K. Onishi, Masaaki Ito, 2004, American journal of physiology. Heart and circulatory physiology.

Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema

M. Sugimoto, M. Kondo, K. Nakatani, 2019, Scientific Reports.

Tissue Type Plasminogen Activator Antigen in Disseminated Intravascular Coagulation

Y. Kumeda, H. Wada, M. Takagi, 1991 .

Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation

T. Miyata, H. Toyoda, H. Wada, 2016, Journal of pediatric hematology/oncology.

Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure

S. Madoiwa, T. Ikezoe, H. Wada, 2020, Thrombosis Journal.

Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

J. Connors, T. Iba, H. Wada, 2021, International Journal of Hematology.

Increased hemostatic molecular markers in patients undergoing anticoagulant therapy.

J. Nishioka, H. Shiku, H. Wada, 2000, Seminars in thrombosis and hemostasis.

Characteristics Behaviors of Coagulation and Fibrinolysis Markers in Acquired Thrombotic Thrombocytopenic Purpura

H. Wada, M. Matsumoto, M. Hayakawa, 2020, Journal of intensive care medicine.

Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus.

H. Shiku, H. Wada, Y. Adachi, 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Acquired Activated Protein C Resistance in Patients with Lupus Anticoagulant and Essential Thrombocythemia

J. Nishioka, E. Gabazza, Koji Suzuki, 1997 .

Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection

K. Shiraki, H. Wada, H. Shimpo, 2021, Journal of clinical medicine.

A Compound Heterozygous Protein C Deficiency with a Single Nucleotide G Deletion Encoding Gly-381 and an Amino Acid Substitution of Lys for Gla-26

Tatsuya Hayashi, J. Nishioka, M. Ido, 1993, Thrombosis and Haemostasis.

Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients

H. Shiku, K. Nakatani, K. Onishi, 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Generation of Tissue Factor Activity by Mononuclear Cells, Vascular Endothelial Cells and Vascular Endothelial Cells incubated with Mononuclear Cells Supernatants.

H. Wada, M. Takagi, M. Tanigawa, 1992 .

Hemostatic Abnormality of Hemophagocytic Syndrome

H. Wada, R. Yatani, K. Kita, 1991 .

Frequency and hemostatic abnormalities in pre-DIC patients.

S. Madoiwa, I. Maruyama, S. Kushimoto, 2010, Thrombosis research.

Increased Soluble Fibrin in Plasma of Patients with Disseminated Intravascular Coagulation

E. Gabazza, H. Shiku, K. Nakatani, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Good or Poor Responses of Hemostatic Molecular Markers in Patients with Hematopoietic Disorders After Treatment of Disseminated Intravascular Coagulation

E. Gabazza, H. Shiku, Y. Okugawa, 2003, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.

E. Gabazza, H. Shiku, H. Wada, 2000, Seminars in thrombosis and hemostasis.

[The changes in von Willebrand factor multimer in a course of thrombotic thrombocytopenic purpura].

H. Wada, M. Tanigawa, M. Masuya, 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Evaluation of the Diagnostic Criteria for the Basic Type of DIC Established by the Japanese Society of Thrombosis and Hemostasis

H. Wada, K. Ohishi, N. Katayama, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

An Evaluation of the Modified Diagnostic Criteria for DIC Established by the Japanese Society of Thrombosis and Hemostasis

H. Wada, K. Ohishi, N. Katayama, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

The valuable diagnosis of DIC and pre-DIC and prediction of a poor outcome by the evaluation of diagnostic criteria for DIC in patients with hematopoietic injury established by the Japanese Society of Thrombosis and Hemostasis.

S. Madoiwa, K. Sugimoto, H. Wada, 2016, Thrombosis research.

Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases.

S. Kushimoto, T. Nobori, H. Wada, 2011, Thrombosis research.

Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation

M. Kusunoki, T. Nobori, H. Wada, 2010, Thrombosis and Haemostasis.

The Usefulness and Limits of FDP/D-dimer for the Diagnosis of DIC

H. Wada, Takeshi Matsumoto, 2008 .

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey

D. Saitoh, T. Iba, H. Wada, 2014, Critical Care.

Diagnostic criteria for DIC based on the prospective study

H. Wada, Katsura Noma, 2010 .

Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.

H. Redl, F. Taylor, G. Peer, 2001, Thrombosis and haemostasis.

Hemostatic Molecular Markers Before Onset of Disseminated Intravascular Coagulation in Leukemic Patients

H. Shiku, H. Wada, N. Sakuragawa, 1998, Seminars in thrombosis and hemostasis.

An evaluation of the Japanese Society on Thrombosis and Hemostasis criteria for disseminated intravascular coagulation as a predictor of prognosis in patients with infection

S. Madoiwa, T. Ikezoe, H. Wada, 2021, International journal of laboratory hematology.

Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trials: comment

H. Wada, K. Suzuki, H. Imai, 2016, Journal of Thrombosis and Haemostasis.

H. Wada, S. Shirakawa, K. Deguchi, 1983, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

Natural History of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome

H. Wada, Y. Yamashita, Takeshi Matsumoto, 2014, Seminars in Thrombosis & Hemostasis.

Blood Level of IL-1β in Disseminated Intravascular Coagulation and Thrombotic Thrombocytopenic Purpura

H. Wada, M. Takagi, M. Tanigawa, 1990 .

Plasma Level of Tumor Necrosis Factor in Disseminated Intravascular Coagulation and Thrombotic Thrombocytopenic Purpura

H. Wada, M. Tanigawa, S. Tamaki, 1990 .

Elevated Plasma Levels of Fibrin Degradation Productsby Granulocyte-Derived Elastase in Patients with Disseminated Intravascular Coagulation

H. Shiku, K. Nakatani, K. Onishi, 2005 .

A Simple Technique to Determine Thrombopoiesis in Thrombocytopenic Patients Using Immature Platelet Fraction (IPF).

H. Shiku, H. Wada, T. Kaneko, 2004 .

[Elevated plasma interleukin-6 in patient with idiopathic thrombocytopenic purpura].

H. Wada, M. Takagi, S. Tamaki, 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Experimental studies on the interaction of thrombin and factor VIII

H. Wada, K. Deguchi, T. Urata, 1981 .

DIC: an update on diagnosis and treatment.

H. Wada, Maki Watanabe, Kei Hasegawa, 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.

H. Wada, S. Chong, D. Oh, 2010, Thrombosis research.

The Roles of Coagulation Disorder and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment.

Y. Umemura, T. Iba, H. Wada, 2021, Archives of medical research.

Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT)

H. Wada, S. Shirakawa, K. Deguchi, 1991, American journal of hematology.

Homozygous protein C deficiency: identification of a novel missense mutation that causes impaired secretion of the mutant protein C.

J. Takamatsu, T. Matsushita, H. Wada, 1992, Journal of Laboratory and Clinical Medicine.

High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism

T. Ikeda, M. Ikejiri, K. Nakatani, 2017, International Journal of Hematology.

Evaluation of hemostatic abnormalities in patients who underwent major hepatobiliary pancreatic surgery using activated partial thromboplastin time-clot waveform analysis.

H. Wada, S. Mizuno, A. Tanemura, 2021, Thrombosis research.

Protection From Pregnancy Loss in Women With Hereditary Thrombophilia When Associated With Fibrinogen Polymorphism Thr331Ala

T. Ikeda, M. Ikejiri, K. Nakatani, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Differential diagnosis of thrombotic thrombocytopenic purpura / hemolytic uremic syndrome

H. Wada, 2008 .

[Factor VIII inhibitor postpartum].

H. Wada, M. Tsuda, S. Shirakawa, 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer.

H. Fuse, Y. Furuya, H. Shiku, 2002, Anticancer research.

Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan".

S. Madoiwa, S. Kushimoto, T. Iba, 2014, Thrombosis research.

[Sinus bradyarrhythmia during administration of all-trans retinoic acid in a patient with acute promyelocytic leukemia].

H. Wada, S. Koizumi, K. Maruhashi, 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Studies on platelet-activating factor (PAF)

H. Wada, S. Shirakawa, K. Deguchi, 1984 .

[A cyclic thrombocytopenia associated with Sjögren syndrome].

H. Wada, M. Takagi, T. Sekine, 1989, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations

H. Wada, H. Mizutani, K. Yamanaka, 2019, Scientific Reports.

A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms

M. Shimaoka, K. Shiraki, H. Wada, 2021, Journal of Clinical Medicine.

Direct stimulation of protein kinase C by arachidonate is associated with platelet activation

H. Wada, S. Shirakawa, M. Nishikawa, 1987 .

Increased tissue factor pathway inhibitor in patients with acute myocardial infarction

H. Shiku, H. Wada, N. Yamada, 1997, American journal of hematology.

An inhibitor against factor V occurring postoperatively in a case of pancreatic cancer.

H. Wada, K. Deguchi, T. Morito, 1981, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

Microangiopathic hemolytic anemia associated with advanced gastric cancer

K. Iriyama, H. Wada, T. Kitagawa, 1997, International Journal of Clinical Oncology.

Increased activated protein C‐protein C inhibitor complex level in patients positive for lupus anticoagulant

H. Wada, T. Hayashi, K. Suzuki, 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Adult respiratory distress syndrome complicating hematological diseases

H. Wada, N. Katayama, K. Kita, 1993, European journal of haematology.

Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.

M. Di Nisio, J. Thachil, D. Saitoh, 2016, Thrombosis research.

Two patients with antiphospholipid antibody developed disseminated intravascular coagulation.

T. Nobori, H. Wada, H. Mizutani, 2013, Internal medicine.

Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies: comment

M. Ikejiri, H. Wada, K. Ohishi, 2019, Journal of thrombosis and haemostasis : JTH.

Lethal hepatic infarction following plasma exchange in living donor liver transplant patients

T. Hamada, T. Nobori, H. Wada, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation

O. Nishida, T. Iba, H. Wada, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation

T. Iba, H. Wada, J. Levy, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Difference between sepsis and trauma diagnosed as sensitive diagnostic criteria for disseminated intravascular coagulation

H. Wada, T. Hatada, 2008, Thrombosis and Haemostasis.

Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.

H. Shiku, H. Wada, Y. Mori, 1996, Polish journal of pharmacology.

Cutoff Values of D-Dimer and FDP in Plasma for the Diagnosis of Thrombosis

A. Uchida, Y. Abe, K. Onishi, 2008 .

[Hemostatic changes before and after the onset of disseminated intravascular coagulation].

H. Wada, M. Takagi, M. Tanigawa, 1989, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers

H. Wada, K. Suzuki, H. Imai, 2015, Journal of thrombosis and haemostasis : JTH.

The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.

A. Sudo, A. Uchida, K. Asanuma, 2013, Clinica chimica acta; international journal of clinical chemistry.

Natural History of Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome

H. Wada, Y. Yamashita, Takeshi Matsumoto, 2014, Seminars in Thrombosis & Hemostasis.

[Cytokine levels in patients with thrombotic thrombocytopenic purpura].

H. Wada, S. Shirakawa, N. Minami, 1993, Nihon rinsho. Japanese journal of clinical medicine.

Fibrinolysis in patients with lupus anticoagulant

H. Wada, S. Shirakawa, M. Nishikawa, 1986 .

Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases.

S. Kushimoto, T. Nobori, H. Wada, 2011, Thrombosis research.

Cerebral venous thrombosis

H. Wada, H. Tomimoto, A. Shindo, 2014 .

Harmonized guidance for disseminated intravascular coagulation from the International Society on Thrombosis and Haemostasis and the current status of anticoagulant therapy in Japan: a rebuttal

M. Di Nisio, J. Thachil, S. Gando, 2013, Journal of thrombosis and haemostasis : JTH.

A Case of Hemorrhagic Moyamoya Disease Associated with Von Willebrand Disease.

N. Toma, H. Wada, R. Yasuda, 2019, World neurosurgery.

Hemostatic abnormalities in the acute phase of trauma.

H. Wada, Takeshi Hatada, 2010, Thrombosis research.